Who
Chad M. Robins
CEO and Chairman
Company insider
Files Form 4 as: CEO and Chairman, Adaptive Biotechnologies.
In numbers
- Trades disclosed
- 293
- Buys
- 0
- Sells
- 86
- Bought
- $0
- Sold
- $124.8M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jul 2019
- Last trade
- 18 Aug 2026
- Last filed
- 19 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Aug 2026filed 19 Aug 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —278,676 at $0.00 | filing |
| 18 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $1.8M278,676 at $6.55 | filing |
| 18 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $6.8M278,472 at $24.48 | filing |
| 18 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $5,129204 at $25.14 | filing |
| 18 Aug 2026filed 19 Aug 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —278,676 at $0.00 | filing |
| 18 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $1.8M278,676 at $6.55 | filing |
| 18 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $6.8M278,472 at $24.48 | filing |
| 18 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $5,129204 at $25.14 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $2.1M321,324 at $6.55 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $8.0M318,799 at $25.08 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $65K2,525 at $25.57 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —321,324 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —321,324 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $2.1M321,324 at $6.55 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $8.0M318,799 at $25.08 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $65K2,525 at $25.57 | filing |
| 8 Apr 2026filed 8 Apr 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $566K37,263 at $15.19 | filing |
| 8 Apr 2026filed 8 Apr 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $566K37,263 at $15.19 | filing |
| 6 Apr 2026filed 8 Apr 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $1.2M83,332 at $14.41 | filing |
| 6 Apr 2026filed 8 Apr 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $1.2M83,332 at $14.41 | filing |
News
Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 11,881 Shares of Company StockADPT · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Chad M. Robins; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.